Urine Transitional Epithelial Test

When a urinalysis report mentions transitional epithelial cells, it is telling you something about the inner lining of your urinary tract. These cells normally sit in layers along the inside of your bladder, ureters, and the drainage system inside your kidneys, and they peel off in small numbers all the time. A larger than usual count, or unusual-looking versions of these cells, can hint at infection, irritation, or in rare cases something more serious.

This is not a marker most people order on its own. It shows up as one line on a standard urinalysis panel, and how useful that line is depends heavily on what else is on the report. Knowing what these cells are, what they can and cannot tell you, and where they fit alongside other findings is the difference between a number you ignore and a clue that prompts the right follow-up.

What These Cells Actually Are

The urothelium is the tissue that lines the renal pelvis (where urine collects inside the kidney), the ureters, the bladder, and the proximal urethra. It is built in layers, with surface umbrella cells forming a tight seal that keeps urine from leaking back into the body and shields the tissue underneath from bacteria. When cells from this lining slough off, they appear in urine as transitional epithelial cells, sometimes called urothelial cells.

A small number of these cells in urine is normal. The lining renews itself constantly. The clinical question is whether the number, depth (surface versus deeper layers), or appearance suggests something more than routine turnover. Deeper transitional cells, for example, can indicate more severe damage to the lining, which suggests an active process worth investigating rather than background shedding.

This Is Not the Same as Renal Tubular Cells

Routine urinalysis reports often group epithelial cells into three categories: squamous, transitional, and renal tubular. They are not interchangeable. Squamous cells usually reflect contamination from the genital area. Renal tubular epithelial cells (RTECs) come from inside the kidney's filtering tubules and signal tubular injury. Transitional cells come from the drainage and storage parts of the urinary tract, not the filtering part.

This distinction matters because the diagnostic weight is not equal. In a study of 506 symptomatic urinary tract infection patients, renal tubular cells showed acceptable accuracy for identifying upper urinary tract infection, while transitional cells did not perform well as a marker for the same question. Many labs do not subtype epithelial cells at all, partly because telling them apart under the microscope is genuinely hard. In one large survey, even trained staff correctly identified transitional cells only about 70 percent of the time, and agreement among nephrologists reviewing the same urine images was poor for transitional cells (a kappa of 0.14, where 1.0 would be perfect agreement).

What Elevated Transitional Cells Can Signal

A higher than expected count of transitional cells, especially when paired with other abnormal findings, can point to several distinct issues. The most common reasons fall into three groups.

• Infection or inflammation: in pregnant women near term, what looked like generic epithelial contamination in urine samples was actually urothelial cells, often with bacteria stuck to them (called clue cells), pointing to bacteriuria the standard culture missed. People with chronic lower urinary tract symptoms similarly carry bacteria attached to shed urothelial cells that routine culture often misses.
• Urothelial injury: deeper layer transitional cells can appear when something has stripped or inflamed the lining more aggressively than routine turnover, including from catheters, stones, or persistent inflammation.
• Urothelial cancer: atypical or clearly abnormal transitional cells in urine raise concern for bladder or upper tract cancer. This is the territory where cytology and add-on tests such as FISH (a technique that looks for chromosomal changes in shed cells) and protein-based markers come into play.

Bladder and Upper Tract Cancer

Most bladder cancers are urothelial carcinomas, which means they arise from the same cells you are looking at on a urinalysis. Shed cancer cells can show up in voided urine, which is why specialized tests built on top of basic cell counts exist. These tests do not rely on a raw count of transitional cells; they look for specific molecular or chromosomal features in the cells that come out in urine.

The performance numbers are worth knowing because they show how much more information is available beyond the basic line item. A multitarget chromosomal test on urine cells (UroVysion FISH) detects bladder cancer in a substantial share of cases when standard cytology is uncertain or negative. An antibody-based test called Immunocyt is more sensitive than cytology alone for detecting urothelial cancer, especially low-grade tumors. A urine test for a protein called cytokeratin 20 (CK20) has been reported positive in around 91 percent of bladder cancer cases and rarely in people without cancer. None of these come standard with a urinalysis. They are ordered when the clinical picture or the cytology raises concern.

Kidney Transplant and BK Virus

In people with kidney transplants, a virus called BK polyomavirus can damage both the kidney's filtering tubules and the urothelium. Infected cells, including transitional cells, can be detected in urine sediment by staining or by polymerase chain reaction (PCR, a technique that detects viral DNA). This is a specialty use and applies almost exclusively to transplant recipients, but it illustrates that the same cell line on a urinalysis can carry very different meaning depending on the clinical setting.

Reference Ranges

There are no standardized clinical cutpoints for transitional epithelial cells in urine. Labs typically report findings semi-quantitatively (none, few, moderate, many, or per high-power field) rather than as a precise concentration. Reporting also varies widely. In a survey of 1,336 Brazilian laboratories, most did not separate epithelial cells into subtypes at all, and practices for what triggers a report differed by site. This makes single-number reference ranges unreliable, and any cutoff you see on a report should be interpreted within that lab's specific method.

Use this as orientation, not a target. Your lab may use different categories, and a single result outside the typical range is not in itself a diagnosis.

Source: descriptive categorization based on published urinalysis reporting practices. Compare your results within the same lab over time for the most meaningful trend.

Why a Single Reading Is Not Enough

Urine composition shifts constantly with hydration, time of day, recent activity, medications, and what fraction of the void was collected. Add the technical difficulty of correctly identifying transitional cells under the microscope, and a single elevated reading is a starting point, not a verdict. The most informative pattern is a result that stays elevated or trends upward across two or three samples collected on different days, alongside other supporting findings.

A practical cadence: if a routine urinalysis shows more transitional cells than expected and you have any symptoms or known risk factors, repeat the test within 2 to 4 weeks under controlled conditions (mid-stream clean catch, adequate hydration, no recent catheterization). If the second sample is still abnormal, that pattern is worth investigating. If you are tracking after a known issue (recent infection, stone, or procedure), retesting at 4 to 8 weeks helps confirm the lining has settled. For routine preventive monitoring, an annual urinalysis is a reasonable floor.

When Results Can Be Misleading

Several factors can push the number up without indicating disease, or hide a real problem behind an apparently clean result.

• Collection method: a recent urinary catheter or cystoscopy can shed transitional cells mechanically. A first-catch sample versus a midstream sample collects different fractions of the void and different cell mixes.
• Contamination and confusion: squamous epithelial cells from the perineum are often miscounted or lumped together with transitional cells, especially in samples that were not collected as a clean catch.
• Hydration and timing: dilute urine and the time of day can change how cells concentrate in the sample, and first-morning urine carries a different load than later-day samples.
• Subtyping inconsistency: many labs report only generic 'epithelial cells.' Two reports from different labs may not be directly comparable even for the same person.

What to Do With an Abnormal Result

An isolated finding of more transitional cells than expected is rarely actionable on its own. The decision pathway depends on what else is on the report and your context.

• With bacteria, nitrites, or leukocytes: the most likely explanation is infection. A urine culture with sensitivities is the next step.
• With blood in the urine: especially if you are over 40, have smoked, or have a family history of urinary cancers, the next steps are typically a urology referral, imaging of the upper tract (CT urogram or ultrasound), and cystoscopy. Urine cytology and one of the urinary biomarker tests (FISH, Immunocyt, or a methylation panel) may be added.
• With atypical cell morphology noted on the report: ask whether urine cytology was performed or whether the sample needs to be sent for it. Atypia is the line that should always prompt a specialist conversation.
• In a kidney transplant recipient: elevated transitional cells alongside any change in kidney function warrants BK virus testing and a nephrology review.

What this means for you: this line on a urinalysis is best treated as a flag, not a diagnosis. Treat it the way you would a smoke alarm. One beep does not mean the house is on fire, but it earns a quick check before you move on.